Highly variable reporting of incidental findings in a national cohort of US veterans screened for lung cancer
The US Preventive Services Task Force (USPSTF) recommends lung cancer screening (LCS) for high-risk individuals based on trials demonstrating reductions in lung cancer-specific and all-cause mortality. In the National Lung Screening Trial, 7.5% of CT scans identified clinically significant incidental findings (IF), while subsequent protocolized studies demonstrated higher prevalence of IF (up to 40.7%).1 Identifying IF has uncertain benefits but measurable costs to the patient and medical system.
Source: Clinical Imaging - Category: Radiology Authors: Lauren Kearney, Caitlin Butler, Eduardo Nunez, Shirley Qian, Christopher G. Slatore, Lucy Spalluto, Renda Soylemez Wiener Tags: Cardiothoracic Imaging Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | CT Scan | Heart | Lung Cancer | PET Scan | Radiology | Study